GoAI
Get started
PhoenixBio Co., Ltd. logo

PhoenixBio Co., Ltd.

6190.T

JPXHealthcareBiotechnology

Open in GoAI

Latest quote

¥340

−¥6.00 · -1.73%

Aug 24, 3:30 PM JST

6190.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.

Industry
Biotechnology
Sector
Healthcare
Headquarters
JP
CEO
Takashi Shimada
Listed since
Mar 18, 2016
Employees
55

Market position

Day range

Current ¥340

52-week range

Current ¥340

Open
¥342
Previous close
¥346
Volume
11.8K
1.49× average
Average volume
7.9K
Average daily volume
Market cap
1.38B JPY
Beta
0.37
Market reference 1
50-day average
¥347.24
-2.09% below average
200-day average
¥435.12
-21.86% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.13B JPY
P/E (TTM)
92.39×
P/B (TTM)
0.95×
P/S (TTM)
0.97×
EV / EBITDA
9.68×
Earnings yield
7.00%
Free cash flow yield
3.15%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
75.00%
Operating margin
-2.41%
Net margin
1.05%
Return on equity
8.07%
Return on assets
5.71%
Return on invested capital
3.87%

Financial health

Debt / equity
0.29×
Current ratio
4.4×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends86%44%2%-40%Gross margin, FY2021: 54.94%Gross margin, FY2022: 73.28%Gross margin, FY2023: 69.67%Gross margin, FY2024: 71.89%Gross margin, FY2025: 75.95%Operating margin, FY2021: -12.65%Operating margin, FY2022: 23.94%Operating margin, FY2023: 0.64%Operating margin, FY2024: -8.77%Operating margin, FY2025: 5.29%Net margin, FY2021: -29.28%Net margin, FY2022: 23.23%Net margin, FY2023: 1.54%Net margin, FY2024: -28.91%Net margin, FY2025: 8.00%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 54.94%. Gross margin FY2022 73.28%. Gross margin FY2023 69.67%. Gross margin FY2024 71.89%. Gross margin FY2025 75.95%. Operating margin FY2021 -12.65%. Operating margin FY2022 23.94%. Operating margin FY2023 0.64%. Operating margin FY2024 -8.77%. Operating margin FY2025 5.29%. Net margin FY2021 -29.28%. Net margin FY2022 23.23%. Net margin FY2023 1.54%. Net margin FY2024 -28.91%. Net margin FY2025 8.00%.

Income trends

Revenue

1.57B JPY+1.57%

Operating income

82.77M JPY+217.94M JPY

Net income

125.23M JPY+570.88M JPY
Income trends across reported periods2.38B JPY1.35B JPY325.26M JPY−702.62M JPYRevenue, FY2021: 1.32B JPYRevenue, FY2022: 2.12B JPYRevenue, FY2023: 1.72B JPYRevenue, FY2024: 1.54B JPYRevenue, FY2025: 1.57B JPYOperating income, FY2021: −167.62M JPYOperating income, FY2022: 508.45M JPYOperating income, FY2023: 11.06M JPYOperating income, FY2024: −135.17M JPYOperating income, FY2025: 82.77M JPYNet income, FY2021: −387.97M JPYNet income, FY2022: 493.33M JPYNet income, FY2023: 26.38M JPYNet income, FY2024: −445.65M JPYNet income, FY2025: 125.23M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.32B JPY. Revenue FY2022 2.12B JPY. Revenue FY2023 1.72B JPY. Revenue FY2024 1.54B JPY. Revenue FY2025 1.57B JPY. Operating income FY2021 −167.62M JPY. Operating income FY2022 508.45M JPY. Operating income FY2023 11.06M JPY. Operating income FY2024 −135.17M JPY. Operating income FY2025 82.77M JPY. Net income FY2021 −387.97M JPY. Net income FY2022 493.33M JPY. Net income FY2023 26.38M JPY. Net income FY2024 −445.65M JPY. Net income FY2025 125.23M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue1.57B JPY1.54B JPY1.72B JPY2.12B JPY1.32B JPY
Cost of goods sold376.45M JPY433.28M JPY520.26M JPY567.6M JPY597.03M JPY
Gross profit1.19B JPY1.11B JPY1.2B JPY1.56B JPY727.79M JPY
Research and development191.38M JPY273.75M JPY206.86M JPY205.48M JPY219.77M JPY
Selling, general, and administrative914.93M JPY969.53M JPY975M JPY836M JPY665M JPY
Operating expenses1.11B JPY1.24B JPY1.18B JPY1.05B JPY895.41M JPY
Interest income9.41M JPY8.33M JPY5.96M JPY2.23M JPY203K JPY
Interest expense4.8M JPY5.25M JPY2.93M JPY3.07M JPY952K JPY
Depreciation and amortization33.75M JPY28.2M JPY25.23M JPY23.7M JPY86.24M JPY
Operating income82.77M JPY−135.17M JPY11.06M JPY508.45M JPY−167.62M JPY
Net income125.23M JPY−445.65M JPY26.38M JPY493.33M JPY−387.97M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
30.81
FY2025
Latest fiscal-year revenue
1.57B JPY
FY2025 · +1.57% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend118.7732.85-53.06-138.98FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend2.2B1.88B1.56B1.24BFY21FY22FY23FY24FY25

Continue in GoAI

Research 6190.T

research.disclaimer